GRI Bio, Inc. filed its S-4 on Dec 23, 2022 for the period ending Dec 31, 2021. In this report its auditor, Sadler, Gibb and Associates, LLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 USD | -1.88% | -18.23% | -95.52% |
1st Jan change | Capi. | |
---|---|---|
-95.52% | 456K | |
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- GRI Stock
- News GRI Bio, Inc.
- GRI Bio, Inc. Auditor Raises 'Going Concern' Doubt